60

Zhende Medical Co Ltd

603301 · SHG · Healthcare / Medical Instruments & Supplies

83.50CNY-1.40 (-1.65%)

Price History

Full chart

Market Stats

Previous Close84.90
Open85.00
Day Range82.54 – 86.28
52-Week Range46.80 – 104.84
Volume929.04K
Market Cap19.84B
P/E (TTM)71.59
Forward P/E0.00
EPS1.05
Dividend Yield0.40%
Beta0.41
50-Day Avg83.19
200-Day Avg84.34

About

Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China and internationally. The company offers a gauze swab, lap sponge, and fluff gauze swab; non-woven swab; PBT bandage, elastic bandage, crepe bandage, crochet bandage, selvedge bandage, under-cast padding, and fluff gauze roll; dressing set; first aid kit; cotton pad and applicator; and gauze roll and abdominal pad. It also provides surgical gown, scrub suit, warm-up jacket, surgical headwear, and isolation gown; surgical drape; standard surgical pack and custom procedure pack; disposable sterile; equipment cover; OP Tape, hand towel, and fluid collection pouch; latex surgical glove; CSR wrap; infection control and protection products; basic nursing care products; pressure therapy and immobilization products; stoma and modern wound care products, and respiratory anesthesia consumable; and warming blanket system. In addition, the company offers an isolation gown, surgical cap, shoe cover, medical mask, and particular respirator; compression bandage and compression stocking; wound care products; pre-filled flush syringes; and ostomy and accessories. Further, it provides respiratory health, home cleaning, IP collaboration, nasal care, protective gear and assistive devices, and personal beauty products. Zhende Medical Co., Ltd. was incorporated in 1994 and is headquartered in Shaoxing, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Jianguo Lu
  • Employees7.91K
  • HeadquartersNo. 55, Xiangji Road, Shaoxing, China, 312035, China
  • Websitehttps://www.zhende.com

Leadership

  • Mr. Jianguo LuChairman of the Board & GM · b. 1970
  • Ms. Haiping JinCFO & Financial Director · b. 1976
  • Mr. Zhendong ShenDirector & Deputy GM · b. 1974
  • Mr. Dasheng XuDeputy GM & Director · b. 1974
  • Mr. Baohai JiSecretary of the Board of Directors · b. 1980
  • Mr. Junwu HuDeputy General Manager · b. 1977
  • Mr. Jiangtao LongDeputy General Manager · b. 1976
  • Shuyan MaHead of Accounting & Accounting Supervisor

Financials

Income Statement

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue986.91M1.02B1.03B1.31B1.43B1.87B10.40B5.09B6.14B4.13B4.26B4.33B
Growth (%)-+3.45%+1.36%+26.24%+9.37%+30.71%+456.75%-51.04%+20.54%-32.76%+3.32%+1.54%
Cost of Revenue772.76M719.68M711.75M924.37M988.75M1.28B5.57B3.35B4.06B2.85B2.85B2.86B
Gross Profit214.15M301.33M323.15M382.07M440.10M591.58M4.83B1.74B2.07B1.28B1.41B1.47B
Gross Margin21.70%29.51%31.23%29.25%30.80%31.67%46.45%34.14%33.80%30.93%33.16%33.92%
Operating Expense197.83M218.84M243.98M234.07M286.69M391.24M1.29B916.47M1.26B1.05B922.08M1.08B
Operating Income16.32M82.49M79.17M148.00M153.42M200.33M3.54B821.97M812.81M225.95M491.80M388.30M
Operating Margin1.65%8.08%7.65%11.33%10.74%10.73%34.01%16.14%13.24%5.47%11.53%8.97%
EBITDA101.30M175.54M174.27M230.34M235.00M294.76M3.63B978.59M1.02B492.77M744.38M653.70M
EBITDA Margin10.26%17.19%16.84%17.63%16.45%15.78%34.95%19.22%16.65%11.94%17.46%15.10%
Net Income21.77M79.06M82.84M121.77M130.20M156.89M2.55B595.86M679.88M198.40M385.17M260.82M
Net Income Margin2.21%7.74%8.00%9.32%9.11%8.40%24.52%11.70%11.08%4.81%9.03%6.02%
R&D31.75M32.33M31.10M43.66M56.91M50.95M259.71M153.14M227.00M138.95M135.49M142.43M
R&D as % of Total Revenue3.22%3.17%3.01%3.34%3.98%2.73%2.50%3.01%3.70%3.37%3.18%3.29%
Interest Expense38.93M45.10M29.53M24.35M21.93M30.23M22.84M27.14M34.57M30.91M31.60M31.49M
Interest Expense % of Total Revenue3.94%4.42%2.85%1.86%1.54%1.62%0.22%0.53%0.56%0.75%0.74%0.73%

Balance Sheet

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.11B1.27B1.13B1.29B1.85B2.67B6.40B6.42B7.90B7.27B7.58B8.40B
Total Liabilities1.00B1.01B689.75M733.69M725.29M1.27B1.93B1.98B2.14B1.66B1.68B2.44B
Total Equity99.12M258.65M437.46M559.23M1.12B1.36B4.18B4.07B5.54B5.37B5.64B5.69B
Cash93.56M216.82M63.47M114.39M302.37M646.25M1.81B1.36B2.08B1.05B596.16M825.31M
Total Debt664.70M435.92M390.00M410.00M365.73M714.57M453.48M848.36M564.30M459.54M551.34M-
Net Debt571.14M219.10M326.53M295.61M63.35M68.32M-1.36B-509.94M-1.51B-476.70M-44.82M324.79M

Cash Flow

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow83.63M142.70M138.57M182.34M20.25M197.76M3.12B817.63M1.25B452.11M461.14M538.49M
Investing Cash Flow-59.77M-133.37M50.15M-136.40M-161.63M-319.08M-1.79B-554.42M-992.79M-1.06B-767.99M-
Financing Cash Flow-27.33M46.29M-265.81M-16.70M349.28M428.15M-277.66M-379.57M456.00M-423.28M-169.43M-
Capital Expenditure57.93M23.13M159.23M144.45M226.70M273.79M1.09B695.47M754.12M599.24M769.69M550.22M
Free Cash Flow25.69M119.57M-20.65M37.90M-206.46M-76.03M2.03B122.16M491.92M-147.13M-308.55M-11.73M
Dividends Paid60.06M37.79M22.63M21.36M21.02M35.00M60.20M522.57M164.25M423.72M159.40M201.49M
FCF to OCF30.72%83.79%-14.90%20.78%-1019.75%-38.44%64.98%14.94%39.48%-32.54%-66.91%-2.18%
Dividend Paid to FCF233.78%31.60%-109.56%56.36%-10.18%-46.04%2.97%427.76%33.39%-287.99%-51.66%-1718.22%

Earnings

Report DateAug 29, 2018Sep 30, 2018Dec 31, 2018Apr 29, 2019Aug 12, 2019Oct 29, 2019Dec 31, 2019Apr 29, 2020Aug 17, 2020Oct 28, 2020Dec 31, 2020Apr 27, 2021Aug 26, 2021Oct 25, 2021Mar 29, 2022Apr 29, 2022Aug 29, 2022Oct 27, 2022Dec 31, 2022Apr 25, 2023
EPS Estimate--------------------
EPS Actual0.170.170.230.160.140.180.320.404.055.181.991.120.550.460.510.520.710.810.850.55
Surprise--------------------
TimingAfter-hours--Pre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-market-Pre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-market-Pre-market

Key Statistics & Ratios

Market Cap19.84B
Enterprise Value21.73B
Trailing P/E71.59
Forward P/E0.00
Price / Sales4.45
Price / Book3.76
EPS1.05
Book Value21.51
Revenue (TTM)4.45B
Gross Profit (TTM)1.48B
EBITDA640.31M
Profit Margin6.22%
Operating Margin7.84%
Return on Equity4.85%
Return on Assets2.50%
Shares Outstanding263.88M
Shares Float102.49M
Beta0.41
Dividend Yield0.40%
Dividend Rate0.30
Payout Ratio28.57%

Dividends

20231×
0.75Jun 20, 2023
20221×
0.60Jun 15, 2022
20211×
2.30Jul 22, 2021
20201×
0.43Jun 8, 2020
20191×
0.25May 24, 2019

Stock Splits

  • Jun 8, 20207:5
  • May 24, 20197:5